Insider Trading activities of Cytokinetics Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Cytokinetics Inc since 2005. The reporting company's ticker symbol is CYTK. The reporting company's CIK number is 1061983.
The total value of stock buying since 2005 is $7,777,414.
The total value of stock sales since 2005 is $14,534,105.
The total value of stock option exercises since 2005 is $2,442,213.


 1   2 

Table 2. Detailed insider stock purchases, sales, and option exercises of Cytokinetics Inc insiders (CYTK) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-01-02 Morgans David J Jr (EVP-Preclinical R&D) Sale 5,000 2.81 14,040
2008-12-01 Morgans David J Jr (EVP-Preclinical R&D) Sale 5,000 2.21 11,065
2008-11-03 Morgans David J Jr (EVP-Preclinical R&D) Sale 5,000 2.93 14,660
2008-09-26 Sabry James H (Executive Chairman) Sale 20,000 4.83 96,660
2008-09-24 Sabry James H (Executive Chairman) Sale 20,000 4.80 95,920
2008-09-15 Blum Robert I (President & CEO) Sale 5,838 5.00 29,190
2008-09-15 Blum Robert I (President & CEO) Option Ex 5,838 1.20 7,005
2008-08-29 Blum Robert I (President & CEO) Sale 9,676 5.30 51,253
2008-08-29 Blum Robert I (President & CEO) Option Ex 9,676 1.20 11,611
2008-08-15 Blum Robert I (President & CEO) Sale 5,300 5.00 26,500
2008-08-15 Blum Robert I (President & CEO) Option Ex 3,889 1.20 4,666
2008-07-31 Blum Robert I (President & CEO) Sale 20,651 5.00 103,255
2008-07-31 Blum Robert I (President & CEO) Option Ex 13,302 2.00 26,604
2008-04-25 Spudich James A (Director) Sale 2,000 3.31 6,630
2008-03-20 Spudich James A (Director) Sale 2,000 3.38 6,770
2008-02-27 Spudich James A (Director) Sale 2,000 3.50 7,000
2008-01-08 Spudich James A (Director) Sale 3,000 4.52 13,559
2007-12-14 Blum Robert I (President & CEO) Sale 6,702 5.39 36,123
2007-12-14 Blum Robert I (President & CEO) Option Ex 6,702 2.00 13,404
2007-12-10 Spudich James A (Director) Sale 3,000 5.64 16,908
2007-12-03 Sabry James H (Executive Chairman) Sale 7,000 5.00 35,000
2007-12-03 Sabry James H (Executive Chairman) Option Ex 7,000 1.20 8,400
2007-11-30 Blum Robert I (President & CEO) Sale 6,805 5.19 35,317
2007-11-30 Blum Robert I (President & CEO) Option Ex 6,805 2.00 13,610
2007-11-15 Blum Robert I (President & CEO) Sale 7,009 5.00 35,045
2007-11-15 Blum Robert I (President & CEO) Option Ex 7,009 2.00 14,018
2007-11-02 Spudich James A (Director) Sale 3,000 5.19 15,570
2007-11-01 Sabry James H (Executive Chairman) Sale 7,000 5.00 35,000
2007-11-01 Sabry James H (Executive Chairman) Option Ex 7,000 1.20 8,400
2007-10-31 Blum Robert I (President & CEO) Sale 7,419 5.03 37,317
2007-10-31 Blum Robert I (President & CEO) Option Ex 7,419 2.00 14,838
2007-10-15 Blum Robert I (President & CEO) Sale 8,237 6.05 49,809
2007-10-15 Blum Robert I (President & CEO) Option Ex 8,237 2.00 16,474
2007-10-03 Spudich James A (Director) Sale 6,000 5.41 32,460
2007-10-01 Sabry James H (Executive Chairman) Sale 7,000 5.05 35,329
2007-10-01 Sabry James H (Executive Chairman) Option Ex 7,000 1.20 8,400
2007-09-28 Blum Robert I (President & CEO) Sale 9,874 5.09 50,258
2007-09-28 Blum Robert I (President & CEO) Option Ex 9,874 2.00 19,748
2007-09-28 Morgans David J Jr (SVP-Preclinical R&D) Sale 5,000 5.09 25,450
2007-09-14 Morgans David J Jr (SVP-Preclinical R&D) Sale 5,000 4.75 23,750
2007-09-14 Morgans David J Jr (SVP-Preclinical R&D) Option Ex 32,000 1.20 38,400
2007-09-05 Spudich James A (Director) Sale 3,000 4.96 14,880
2007-08-30 Blum Robert I (President & CEO) Sale 6,548 5.11 33,460
2007-08-30 Blum Robert I (President & CEO) Option Ex 6,548 1.29 8,446
2007-08-17 Dow Stephen M Buy 20,000 5.07 101,420
2007-08-15 Blum Robert I (President & CEO) Sale 6,497 5.04 32,744
2007-08-15 Blum Robert I (President & CEO) Option Ex 6,497 .58 3,768
2007-08-10 Trautman Jay K (VP, Discovery Research) Option Ex 30,000 1.20 36,000
2007-08-02 Spudich James A (Director) Sale 3,000 5.23 15,690
2007-08-01 Sabry James H (Executive Chairman) Sale 7,000 5.00 35,000
2007-08-01 Sabry James H (Executive Chairman) Option Ex 7,000 1.20 8,400
2007-07-31 Blum Robert I (President & CEO) Sale 6,394 5.00 31,970
2007-07-31 Blum Robert I (President & CEO) Option Ex 267 .58 154
2007-07-16 Blum Robert I (President & CEO) Sale 6,188 5.48 33,910
2007-07-16 Blum Robert I (President & CEO) Option Ex 60 .58 34
2007-07-03 Spudich James A (Director) Sale 3,000 5.68 17,055
2007-07-02 Sabry James H (Executive Chairman) Sale 7,000 5.71 39,970
2007-07-02 Sabry James H (Executive Chairman) Option Ex 7,000 1.20 8,400
2007-06-29 Blum Robert I (President & CEO) Sale 5,775 5.86 33,864
2007-06-29 Morgans David J Jr (SVP-Preclinical R&D) Sale 5,000 6.00 30,000
2007-06-15 Blum Robert I (President & CEO) Sale 4,950 6.46 31,977
2007-06-15 Morgans David J Jr (SVP-Preclinical R&D) Sale 5,000 6.46 32,300
2007-06-15 Morgans David J Jr (SVP-Preclinical R&D) Option Ex 27,500 1.20 33,000
2007-06-11 Sabry James H (Executive Chairman) Sale 7,000 6.39 44,730
2007-06-11 Sabry James H (Executive Chairman) Option Ex 7,000 .89 6,230
2007-06-04 Spudich James A (Director) Sale 3,000 6.52 19,560
2007-05-29 Blum Robert I (President & CEO) Sale 3,300 6.50 21,459
2007-05-11 Spudich James A (Director) Sale 3,000 6.67 20,025
2007-05-10 Trautman Jay K (VP, Discovery Research) Sale 1,500 7.01 10,515
2007-04-10 Trautman Jay K (VP, Discovery Research) Sale 1,500 7.05 10,578
2007-03-09 Trautman Jay K (VP, Research) Sale 1,500 7.12 10,680
2007-02-09 Trautman Jay K (VP, Research) Sale 1,500 8.00 12,000
2007-02-01 Sabry James H (CEO) Sale 7,000 7.89 55,216
2007-02-01 Sabry James H (CEO) Option Ex 7,000 1.20 8,400
2007-01-16 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 8.31 41,550
2007-01-16 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2007-01-11 Spudich James A (Director) Sale 2,200 8.31 18,293
2007-01-11 Trautman Jay K (VP, Research) Sale 1,000 8.30 8,300
2007-01-03 Sabry James H (CEO) Sale 7,000 8.70 60,865
2007-01-03 Sabry James H (CEO) Option Ex 7,000 1.20 8,400
2006-12-21 Spudich James A (Director) Sale 2,200 6.83 15,032
2006-12-15 Blum Robert I (President) Sale 5,000 6.94 34,700
2006-12-15 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-12-11 Trautman Jay K (VP, Research) Sale 1,000 7.30 7,300
2006-12-01 Sabry James H (CEO) Sale 7,000 7.34 51,380
2006-12-01 Sabry James H (CEO) Option Ex 7,000 .89 6,230
2006-11-30 Blum Robert I (President) Sale 5,000 7.29 36,465
2006-11-30 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-11-21 Spudich James A (Director) Sale 2,200 7.73 17,012
2006-11-15 Blum Robert I (President) Sale 5,000 7.62 38,090
2006-11-15 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-11-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.80 39,000
2006-11-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2006-11-10 Trautman Jay K (VP, Research) Sale 1,000 7.29 7,290
2006-11-01 Sabry James H (CEO) Sale 7,000 7.30 51,100
2006-11-01 Sabry James H (CEO) Option Ex 7,000 .58 4,059
2006-10-30 Blum Robert I (President) Sale 5,000 7.01 35,075
2006-10-30 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-10-24 Spudich James A (Director) Sale 2,200 7.01 15,433
2006-10-19 Trautman Jay K (VP, Research) Sale 1,000 7.00 7,000
2006-10-16 Blum Robert I (President) Sale 5,000 6.75 33,745
2006-10-16 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-10-13 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 6.67 33,350
2006-10-13 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2006-10-02 Blum Robert I (President) Sale 5,000 6.38 31,880
2006-10-02 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-10-02 Sabry James H (President and CEO) Sale 7,000 6.44 45,080
2006-10-02 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-09-29 Spudich James A (Director) Sale 2,200 6.49 14,267
2006-09-15 Blum Robert I (President) Sale 5,000 6.77 33,830
2006-09-15 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-09-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.02 35,100
2006-09-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2006-09-12 Trautman Jay K (VP, Research) Sale 1,000 7.00 7,000
2006-09-01 Sabry James H (President and CEO) Sale 7,000 6.79 47,530
2006-09-01 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-08-30 Blum Robert I (President) Sale 5,000 6.44 32,200
2006-08-30 Blum Robert I (President) Option Ex 5,000 .58 2,900
2006-08-25 Spudich James A (Director) Sale 2,200 6.07 13,356
2006-08-18 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 6.00 30,000
2006-08-18 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2006-08-15 Blum Robert I (President) Sale 4,999 5.45 27,259
2006-08-15 Blum Robert I (President) Option Ex 4,999 .58 2,899
2006-08-01 Sabry James H (President and CEO) Sale 7,000 5.86 40,985
2006-08-01 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-07-31 Blum Robert I (President) Sale 4,999 5.63 28,124
2006-07-31 Blum Robert I (President) Option Ex 4,999 .58 2,899
2006-07-26 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 3,490 6.00 20,940
2006-07-26 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 3,490 1.20 4,188
2006-07-25 Spudich James A (Director) Sale 2,200 5.88 12,940
2006-07-25 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 1,510 6.00 9,060
2006-07-25 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 1,510 1.20 1,812
2006-07-17 Blum Robert I (President) Sale 4,998 5.51 27,563
2006-07-17 Blum Robert I (President) Option Ex 4,998 .58 2,898
2006-07-03 Sabry James H (President and CEO) Sale 7,000 6.54 45,766
2006-07-03 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-06-30 Blum Robert I (President) Sale 4,995 6.61 33,016
2006-06-30 Blum Robert I (President) Option Ex 4,995 .58 2,897
2006-06-29 Spudich James A (Director) Sale 2,200 6.49 14,278
2006-06-09 Trautman Jay K (VP, Research) Sale 1,000 7.03 7,030
2006-06-01 Sabry James H (President and CEO) Sale 7,000 6.88 48,146
2006-06-01 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-05-30 Blum Robert I (President) Sale 4,980 7.06 35,158
2006-05-30 Blum Robert I (President) Option Ex 4,980 .58 2,888
2006-05-22 Spudich James A (Director) Sale 2,200 7.29 16,038
2006-05-15 Blum Robert I (President) Sale 4,961 6.99 34,672
2006-05-15 Blum Robert I (President) Option Ex 4,961 .58 2,877
2006-05-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.03 35,150
2006-05-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.20 6,000
2006-05-10 Trautman Jay K (VP, Research) Sale 1,000 7.87 7,870
2006-05-01 Blum Robert I (EVP, Corp. Development & CBO) Sale 4,922 7.17 35,275
2006-05-01 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 4,922 .58 2,854
2006-05-01 Sabry James H (President and CEO) Sale 7,000 7.18 50,260
2006-05-01 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-04-17 Blum Robert I (EVP, Corp. Development & CBO) Sale 4,844 7.34 35,554
2006-04-17 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 4,844 .58 2,809
2006-04-17 Trautman Jay K (VP, Disc Biology & Technology) Sale 1,000 7.34 7,340
2006-04-17 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.34 36,700
2006-04-17 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.00 5,000
2006-04-04 Spudich James A (Director) Sale 2,200 7.61 16,748
2006-04-03 Sabry James H (President and CEO) Sale 7,000 7.60 52,908
2006-04-03 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-03-30 Blum Robert I (EVP, Corp. Development & CBO) Sale 4,688 7.06 33,097
2006-03-30 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 4,688 .58 2,719
2006-03-15 Blum Robert I (EVP, Corp. Development & CBO) Sale 4,375 7.01 30,668
2006-03-15 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 4,375 .58 2,537
2006-03-15 Trautman Jay K (VP, Disc Biology & Technology) Sale 1,000 7.01 7,010
2006-03-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.01 35,050
2006-03-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.00 5,000
2006-03-02 Spudich James A (Director) Sale 2,200 7.11 15,648
2006-03-01 Sabry James H (President and CEO) Sale 7,000 7.14 49,980
2006-03-01 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-02-28 Blum Robert I (EVP, Corp. Development & CBO) Sale 3,750 7.10 26,625
2006-02-28 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 3,750 .58 2,175
2006-02-16 Dow Stephen M Buy 5,800 7.49 43,465
2006-02-15 Blum Robert I (EVP, Corp. Development & CBO) Sale 2,500 7.14 17,850
2006-02-15 Blum Robert I (EVP, Corp. Development & CBO) Option Ex 2,500 .58 1,450
2006-02-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Sale 5,000 7.20 36,000
2006-02-15 Morgans David J Jr (SVP-Drug Discovery and Dev) Option Ex 5,000 1.00 5,000
2006-02-15 Dow Stephen M Buy 1,200 7.20 8,640
2006-02-14 Dow Stephen M Buy 19,162 7.21 138,119
2006-02-13 Dow Stephen M Buy 13,838 7.22 99,951
2006-02-08 Sabry James H (President and CEO) Sale 7,000 7.33 51,289
2006-02-08 Sabry James H (President and CEO) Option Ex 7,000 .58 4,059
2006-02-03 Spudich James A (Director) Sale 2,200 7.71 16,973
2005-11-08 Sabry James H (President and CEO) Sale 2,000 8.50 17,000
2005-11-07 Sabry James H (President and CEO) Sale 6,000 8.70 52,199
2005-11-03 Trautman Jay K (Technology) Sale 32,000 7.45 238,919
2005-11-03 Morgans David J Jr (SVP-Drug Discovery a) Sale 45,000 7.80 351,090
2005-11-02 Morgans David J Jr (SVP-Drug Discovery a) Sale 25,000 7.44 186,074
2004-04-29 Dow Stephen M Buy 25,000 8.49 212,275
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.